Advertisement

Current Sports Medicine Reports

, Volume 2, Issue 2, pp 84–90 | Cite as

Upper respiratory tract infections: Who plays, who sits?

  • John P. Metz
Article

Abstract

In athletes with upper respiratory infections (URIs), the question of who plays and who sits can be difficult to answer. Acute exercise suppresses several aspects of the immune system. None of these immunologic changes, however, consistently correlate with the incidence of URIs in athletes. The risk of infection with exercise seems to follow a J-curve relationship, with regular, moderate exercisers having a lower risk than sedentary people, and regular, strenuous exercisers having the highest risk of all. The decision to allow an athlete to play or not can be guided by the "neck check" rules, and can also take into account nonmedical factors. The athlete with infectious mononucleosis warrants more careful attention, as there are strict guidelines for return-to-play in these individuals, to avoid the possibility of splenic rupture.

Keywords

Natural Killer Cell Activity Acute Exercise Infectious Mononu Marathon Runner Splenic Rupture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Boschert S: Team physician should control ’return to play.’ Family Practice News 2002, 32:36.Google Scholar
  2. 2.
    Goodman J: The immune response. In Basic Clinical Immunology, edn 7. Edited by Stites D, Terr A. New York: Appleton & Lange; 1991.Google Scholar
  3. 3.
    Simon H: Exercise and infection. Physician Sports Med 1987, 15:135.Google Scholar
  4. 4.
    Shephard R, Shek P: Exercise, immunity, and susceptibility to infection: A j-shaped relationship? Physician Sports Med 1999, 27:47–66. This is an in-depth discussion of the evidence for and against the Jcurve hypothesis. More importantly, it discusses the shortcomings of past studies and suggests avenues for further studies.Google Scholar
  5. 5.
    Nieman D: Nutrition, exercise, and immune system function. Clin Sports Med 1999, 18:537–548.PubMedCrossRefGoogle Scholar
  6. 6.
    Gleeson M, McDonald WA, Pyne DB, et al.: Salivary IgA levels and infection risks in elite swimmers. Med Sci Sports Exerc 1999, 31:67–73.PubMedCrossRefGoogle Scholar
  7. 7.
    Eichner R: Infection, immunity, and exercise: what to tell your patients. Physician Sports Med 1993, 21:125.Google Scholar
  8. 8.
    Brenner, I, Shek P, Shephard, B: Infection in athletes. Sports Med 1994, 17:86–107.PubMedCrossRefGoogle Scholar
  9. 9.
    Nieman DC, Nehlsen-Cannarella PA, Markoff AJ, et al.: The effects of moderate exercise training on natural killer cells and acute upper respiratory tract infections. Int J Sports Med 1990, 11:467–473.PubMedCrossRefGoogle Scholar
  10. 10.
    Woods J, Davis J, Smith J, et al.: Exercise and cellular innate immune function. Med Sci Sports Exerc 1999, 31:57–66. This is a thorough review of the effect of exercise on the innate immune system.PubMedCrossRefGoogle Scholar
  11. 11.
    Nieman DC, Nehlsen-Cannarella SL, Fagoaga OR, et al.: Immune function in female elite rowers and non-athletes. Br J Sports Med 2000, 34:181–187.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Moldoveanu AI, Shephard RJ, Shek PN: The cytokine response to physical activity and training. Sports Med 2001, 13:115–138.CrossRefGoogle Scholar
  13. 13.
    Pyne DB: Regulation of neutrophil function during exercise. Sports Med 1991, 17:245–258.CrossRefGoogle Scholar
  14. 14.
    Pedersen BK, Toft AD: Effects of exercise on lymphocytes and cytokines. Br J Sports Med 2000, 34:246–251.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Pedersen B, Rohde T, Zacho M: Immunity in athletes. J Sports Med Phys Fitness 1996, 36:236–245.PubMedGoogle Scholar
  16. 16.
    Gleeson M, McDonald WA, Pyne DB, et al.: Immune status and respiratory illness for elite swimmers during a 12-week training cycle. Int J Sports Med 2000, 21:302–307.PubMedCrossRefGoogle Scholar
  17. 17.
    Gleeson M, McDonald WA, Pyne DB, et al.: Salivary IgA levels and infection risk in elite swimmers. Med Sci Sports Exerc 1999, 31:67–73.PubMedCrossRefGoogle Scholar
  18. 18.
    MacKinnon LT, Hooper S: Mucosal (secretory) immune system responses to exercise of varying intensity and during overtraining. Int J Sports Med 1994, 15:S179-S183.PubMedCrossRefGoogle Scholar
  19. 19.
    Bruunsgaard H, Hartkopp A, Mohr T, et al.: In vivo cell-mediated immunity and vaccination response following prolonged, intense exercise. Med Sci Sports Exerc 1997, 29:1176–1181.PubMedCrossRefGoogle Scholar
  20. 20.
    Nieman DC, Buckley KS, Henson DA, et al.: Immune function in marathon runners versus sedentary controls. Med Sci Sports Exerc 1995, 27:986–992.PubMedCrossRefGoogle Scholar
  21. 21.
    Nieman DC: Exercise, upper respiratory tract infection, and the immune system. Med Sci Sports Exerc 1994, 26:128–139.PubMedCrossRefGoogle Scholar
  22. 22.
    Peters EM, Bateman ED: Ultramarathon running and upper respiratory tract infections: an epidemiological survey. South African Med J 1983, 64:582–584.Google Scholar
  23. 23.
    Nieman DC, Johanssen LM, Lee JW, et al.: Infectious episodes in runners before and after the Los Angeles marathon. J Sports Med Phys Fitness 1990, 30:316–328.PubMedGoogle Scholar
  24. 24.
    Linde F: Running and upper respiratory tract infections. Scand J Sports Sci 1987, 9:21–23.Google Scholar
  25. 25.
    Nieman DC, Johanssen LM, Lee JW: Infectious episodes in runners before and after a roadrace. J Sports Med 1989, 29:289–296.Google Scholar
  26. 26.
    Matthews DE, Ockene IS, Freedson PS, et al.: Moderate to vigorous physical activity and risk of upper-respiratory tract infection. Med Sci Sports Exerc 2002, 34:1242–1248.PubMedCrossRefGoogle Scholar
  27. 27.
    Kostka T, Berthouze SE, Lacour JR, et al.: The symptomatology of upper respiratory tract infections and exercise in elderly people. Med Sci Sports Exerc 2000, 32:46–51.PubMedCrossRefGoogle Scholar
  28. 28.
    Heath GW, Ford ES, Craven TE, et al.: Exercise and the incidence of upper respiratory infections. Med Sci Sports Exerc 1991, 23:152–157.PubMedCrossRefGoogle Scholar
  29. 29.
    Nieman DC, Henson DA, Gusewitch G, et al.: Physical activity and immune function in elderly women. Med Sci Sports Exerc 1993, 25:823–831.PubMedCrossRefGoogle Scholar
  30. 30.
    Pyne DB, Baker MS, Fricker PA, et al.: Effects of an intensive 12-wk training program by elite swimmers on neutrophil oxidative activity. Med Sci Sports Exerc 1995, 27:536–542.PubMedCrossRefGoogle Scholar
  31. 31.
    Fahlman MM, Engels HJ, Morgan AL, et al.: Mucosal IgA response to repeated Wingate tests in females. Int J Sports Med 2001, 22:127–131.PubMedCrossRefGoogle Scholar
  32. 32.
    Klentrou P, Cieslak T, MacNeil M, et al.: Effect of moderate exercise on salivary immunoglobulin A and infection risk in humans. Eur J Applied Physiol 2002, 87:153–158.CrossRefGoogle Scholar
  33. 33.
    Nieman DC: Is infection risk linked to exercise workload? Med Sci Sports Exerc 2000, 32:S406-S411. This article outlines the evidence behind the J-curve hypothesis.PubMedCrossRefGoogle Scholar
  34. 34.
    Weidner TG, Cranston T, Schurr T, et al.: The effect of exercise training on the severity and duration of viral upper respiratory illness. Med Sci Sports Exerc 1998, 30:1578–1583.PubMedCrossRefGoogle Scholar
  35. 35.
    Weidner TG, Anderson BN, Kaminsky LA, et al.: Effect of rhinovirus-caused upper respiratory illness on pulmonary function test and exercise responses. Med Sci Sports Exerc 1997, 29:604–609.PubMedCrossRefGoogle Scholar
  36. 36.
    Blair HS, Greenberg P, Stevens P, et al.: Effects of rhinovirus infection on pulmonary function of healthy human volunteers. Am Rev Respir Dis 1976, 114:95–102.PubMedGoogle Scholar
  37. 37.
    O’Connor S, Deric P, Collins J, et al.: Changes in pulmonary function after naturally acquired respiratory infection in normal persons. Am Rev Respir Dis 1979, 120:1087–1093.PubMedGoogle Scholar
  38. 38.
    Primos WA: Sports and exercise during acute illness. Recommending the right course for patients. Physician Sportsmed 1996, 24:44–53.Google Scholar
  39. 39.
    Maki DG, Reich RM: Infectious mononucleosis in the athlete: diagnosis, complications, and management. Am J Sports Med 1982, 10:162–173.PubMedCrossRefGoogle Scholar
  40. 40.
    Bailey R: Diagnosis and treatment of infectious mononucleosis. Am Fam Physician 1994, 49:879–885.PubMedGoogle Scholar
  41. 41.
    MacKnight JM: Infectious mononucleosis: ensuring a safe return to sport. Physician Sports Med 2002, 30:27–41. This is an excellent review of IM, including a detailed discussion of epidemiology, diagnosis, treatment, and return-to-play criteria.Google Scholar
  42. 42.
    Loftus W, Metreweli C: Ultrasound assessment of mild splenomegaly: spleen/kidney ratio. Pediatr Radiol 1998, 28:98–100.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2003

Authors and Affiliations

  • John P. Metz
    • 1
  1. 1.JFK Family Practice ResidencyEdisonUSA

Personalised recommendations